(Q36618801)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

de Jong RS

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Mulder NH

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Uges DR

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Sleijfer DT

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Höppener FJ

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Groen HJ

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Willemse PH

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

van der Graaf WT

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

5-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

882-887

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.

11 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

DNA topoisomerase I and II as targets for rational design of new anticancer drugs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

Chromosome condensation induced by fostriecin does not require p34cdc2 kinase activity and histone H1 hyperphosphorylation, but is associated with enhanced histone H2A and H3 phosphorylation.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

Topoisomerase Poisons: Harnessing the Dark Side of Enzyme Mechanism

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

Preclinical toxicological evaluation of fostriecin, a novel anticancer antibiotic, in rats

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

Mechanisms of resistance to drugs that inhibit DNA topoisomerases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

Catalytic function of DNA topoisomerase II.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell line.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362650

Anticancer activity of the structurally novel antibiotic Cl-920 and its analogues

28 June 2018

1 reference

12 December 2020

Renal toxicity of the anticancer drug fostriecin

1 reference

12 December 2020

In vitro activity of the novel antitumor antibiotic fostriecin (CI-920) in a human tumor cloning assay

1 reference

12 December 2020

Inhibition of type II topoisomerase by fostriecin

1 reference

12 December 2020

Determination of fostriecin pharmacokinetics in plasma using high-pressure liquid chromatography assay

1 reference

12 December 2020

Antitumor drug fostriecin inhibits the mitotic entry checkpoint and protein phosphatases 1 and 2A

1 reference

12 December 2020

Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier system

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6690141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10070885%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

PubMed publication ID

10070885

1 reference